Aug 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2018 Jun 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.35 3.88 19.40
(+12.2 pct) (+15.5 pct) (+8.5 pct)
Operating 441 mln 248 mln 2.52
(+77.4 pct) (+38.7 pct) (+5.0 pct)
Recurring 446 mln 247 mln 2.50
(+79.9 pct) (+48.1 pct) (+4.6 pct)
Net 287 mln 152 mln 1.69
(+88.3 pct) (+63.9 pct) (+5.8 pct)
EPS 72.99 yen 38.76 yen 429.63 yen
Ann Div 30.00 yen 30.00 yen
-Q2 div NIL NIL
-Q4 div 30.00 yen 30.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T